- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02406079
Impact of Tracheotomy on Procalcitonin
Impact of Tracheotomy on Levels of Serum Procalcitonin in Patients Without Sepsis: a Prospective Study
Study Overview
Detailed Description
Procalcitonin (PCT), a soluble protein composed of 116 amino acids with a sequence identical to that of the calcitonin prohormone, has been considered as a reliable biomarker for evaluating of bacterial infection and sepsis. In healthy individuals, serum PCT concentrations are undetectable, however, in case of severe bacterial infections and sepsis, it increase rapidly released mainly in peripheral blood mononuclear cells and modulated by bacterial lipopolysaccharides (LPS) and sepsis-associated cytokines. An increase number of studies have demonstrated that PCT-guided strategy is a helpful approach to guide antibiotic administrations and clinical interventions in the intensive care unit (ICU).
However, PCT is induced in the plasmas of patients not only at the presence of bacterial infection, but also in stress conditions such as severe trauma and surgery. In these conditions, the increases are moderate. The mechanism of the nonspecific increase is complicated. Other conditions with elevated PCT concentrations include medullary thyroid carcinoma , cancer, anaphylactic shock, heat shock , cardiac arrest, Kawasaki Disease, and so on. These findings suggest that elevated PCT levels lack the speciality to detect sepsis in critically ill patients.
Tracheotomy is one of most performed surgical procedures to assure airway by making a hole in front of the trachea in ICU. There are studies in literature that show the surgical procedures to the neck area cause a surgical stress, an increase in thyroid hormones. The procedure may due to miscellaneous clinical signs by altering in hormone levels, even creating a thyroid storm. As far as we are aware, there is no study on the impact of tracheotomy on PCT concentration. The aim of the study was to evaluated whether tracheotomy affects PCT concentrations in patients without sepsis. Moreover, the investigators assessed whether operative duration and procedure were correlation with the peak PCT level.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- without sepsis requiring tracheotomy
Exclusion Criteria:
- those who did not give their consent or declined treatment during the period of observation
- those with any thyroid diseases past history, such as hyperthyroidism, hypothyroidism and thyroidtumor
- those who received high-dose steroid treatment
- those who received renal replacement therapy (RRT)
- those with severe renal injury (Scr > 300 umol/L)
- those who received antibiotic therapy from 48 hours pre-operation to 72 hours post-operation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: tracheotomy
|
Tracheotomy is one of most performed surgical procedures to assure airway by making a hole in front of the trachea in ICU.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
procalcitonin
Time Frame: 0-72 hours
|
0-72 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CZ-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tracheotomy
-
University Hospital, Clermont-FerrandGroupe Hospitalier Pitie-SalpetriereCompleted
-
Capital Medical UniversityCompleted
-
Centre Hospitalier Universitaire de la RéunionWithdrawn
-
Stefan KlugeCompletedICU Patients | Tracheotomy RequiredGermany
-
University of Southern CaliforniaNot yet recruitingAirway Management | Airway Disease | Tracheotomy PatientsUnited States
-
University Hospital, Clermont-FerrandCompletedICU Patients | Intubation | Pulmonary Function | Tracheotomy | Spontaneously BreathingFrance
-
Capital Medical UniversityNot yet recruitingNeurogenic Dysphagia | Tracheotomy Patients
-
The Second Affiliated Hospital of Kunming Medical...Recruiting
Clinical Trials on tracheotomy
-
Asklepios Neurological Clinic Bad SalzhausenRecruitingTracheostomy HemorrhageGermany
-
Sahlgrenska University Hospital, SwedenCompletedCovid-19 | Respiratory Insufficiency | Corona Virus Infection | ARDS | Tracheostomy ComplicationSweden
-
University Hospital, Clermont-FerrandGroupe Hospitalier Pitie-SalpetriereCompleted
-
Karolinska University HospitalCompletedVentilation Therapy; Complications | Tracheostomy ComplicationSweden
-
Gustave Roussy, Cancer Campus, Grand ParisTerminatedRespiratory InsufficiencyFrance
-
Shanghai Zhongshan HospitalNot yet recruitingRespiratory Distress Syndrome (RDS) | Respiratory IlnessChina
-
Chongqing Medical UniversityCompletedRespiratory FailureChina
-
University Hospital Inselspital, BerneGaslini Children's HospitalCompleted
-
Children's Hospital of Fudan UniversityRecruitingProlonged Mechanical VentilationChina
-
University Hospital, Strasbourg, FranceCompletedDysphagia | Swallowing Disorders | Laryngeal NeoplasmsFrance